BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23438150)

  • 1. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.
    Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K
    J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
    Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
    Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma.
    Chien CY; Su CY; Chuang HC; Fang FM; Huang HY; Chen CH; Chen CM; Huang CC
    Oral Oncol; 2009 Sep; 45(9):798-802. PubMed ID: 19213594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
    Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.
    Klimowicz AC; Bose P; Nakoneshny SC; Dean M; Huang L; Chandarana S; Magliocco AM; Wayne Matthews T; Brockton NT; Dort JC
    Eur J Cancer; 2012 Sep; 48(14):2166-74. PubMed ID: 22892062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
    Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
    Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
    Fujii N; Shomori K; Shiomi T; Nakabayashi M; Takeda C; Ryoke K; Ito H
    J Oral Pathol Med; 2012 Jul; 41(6):444-51. PubMed ID: 22296275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
    Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K
    J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma.
    Pappa E; Nikitakis N; Vlachodimitropoulos D; Avgoustidis D; Oktseloglou V; Papadogeorgakis N
    J Oral Maxillofac Surg; 2014 Jan; 72(1):211-21. PubMed ID: 23992782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
    Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
    Routray S; Kheur SM; Kheur M
    Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
    Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
    J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology.
    Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Forteza J; Fraga M
    J Oral Pathol Med; 2010 Aug; 39(7):571-8. PubMed ID: 20202087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midkine expression in oral squamous cell carcinoma and leukoplakia.
    Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC
    J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
    Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
    Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Salo T; Hagström J; Sorsa T
    J Oral Pathol Med; 2013 May; 42(5):389-95. PubMed ID: 23278563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wu CC; Fang KH; Tsai CY; Chang YL; Liu SC; Kao HK
    Oral Oncol; 2013 Aug; 49(8):802-7. PubMed ID: 23769451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.